Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02355340 · ClinicalTrials.gov registry record
Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- 22
- Enrollment target
NCT02355340 is a clinical trial that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 22 participants.
The verdict
NCT02355340 has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
This research study is evaluating bone mineral density in childhood cancer survivors who have a history of bone fracture.
Interventions
- OTHER Dual energy x-ray absorptiometry (DXA)
- OTHER Peripheral quantitative computed tomography (pQCT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2015-05 |
| Est. Completion | 2024-06-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02355340
The ClinicalTrials.gov registry entry for NCT02355340 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dual energy x-ray absorptiometry (DXA) is the first listed.
NCT02355340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02355340 about?
NCT02355340 is a clinical study titled "Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture". This research study is evaluating bone mineral density in childhood cancer survivors who have a history of bone fracture.
What is the current status of trial NCT02355340?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2015-05. Estimated completion is 2024-06-07.
What interventions are being tested in trial NCT02355340?
The interventions under investigation include: Dual energy x-ray absorptiometry (DXA) (OTHER), Peripheral quantitative computed tomography (pQCT) (OTHER).
Who is sponsoring clinical trial NCT02355340?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.